SPX3,699.66+44.62 1.22%
DIA295.24+2.52 0.86%
IXIC10,981.60+178.68 1.65%

Stifel Maintains Buy on Karuna Therapeutics, Raises Price Target to $295

Stifel analyst Paul Matteis maintains Karuna Therapeutics (NASDAQ:KRTX) with a Buy and raises the price target from $260 to $295.

Benzinga · 09/13/2022 09:48
Stifel analyst Paul Matteis maintains Karuna Therapeutics (NASDAQ:KRTX) with a Buy and raises the price target from $260 to $295.